Madison Avenue Partners, LP
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
20
- Value ($000)
$1,675,691
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001801265
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
GRAHAM HLDGS CO | COM CL B | 384637104 | $289.42 M | 17 % | 245,829 | ||
SANDISK CORP | COM | 80004C200 | $231.41 M | 14 % | 2,062,521 | ||
MKL MARKEL GROUP INC | COM | 570535104 | $161.15 M | 10 % | 84,310 | ||
INDIVIOR PLC | ORD | G4766E116 | $155.84 M | 9 % | 6,463,585 | ||
GMED GLOBUS MED INC | CL A | 379577208 | $145.93 M | 9 % | 2,548,163 | ||
SOLV SOLVENTUM CORP | COM SHS | 83444M101 | $145.15 M | 9 % | 1,988,376 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | $138.86 M | 8 % | 9,511,150 | ||
GLPG GALAPAGOS NV | SPON ADR | 36315X101 | $76.06 M | 5 % | 2,195,775 | ||
BMTA BRITISH AMERN TOB PLC | SPONSORED ADR | 110448107 | $64.96 M | 4 % | 1,223,767 | ||
WLY WILEY JOHN & SONS INC | CL A | 968223206 | $47.38 M | 3 % | 1,170,624 |
Rows Per Page
10
- 10
- 50
- 100